{"title":"Vasopressin as a treatment option for vasodilatory septic shock","authors":"I. Tsuneyoshi, Y. Kanmura","doi":"10.3918/JSICM.15.4","DOIUrl":null,"url":null,"abstract":"1) Kurtzman NA, Boonjarern S. Physiology of antidiuretic hormone and the interrelationship between the hormone and the kidney. Nephron. 1975;15:1 7-85. 2) Kamegai M, Kristensen MS, Warberg J, et al. Carotid baroreflexes and plasma vasopressin in humans during head-up tilt. Am J Physiol. 1992;2 3:R318-23. 3) Tsuneyoshi I, Onomoto M, Yonetani A, et al. Low-dose vasopressin infusion in patients with severe vasodilatory hypotension after prolonged hemorrhage during general anesthesia. J Anesth. 2005;19:170-3. 4) Stoiser B, Mörtl D, Hülsmann M, et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest. 200 ;3 :771-8. 5) Hjelmqvist H, Ullman J, Gunnarsson U, et al. Haemodynamic and humoral responses to repeated hypotensive haemorrhage in conscious sheep. Acta Physiol Scand. 1991;143:554. ) Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med. 2003; 31:1752-8. 7) Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-5. 8) Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med. 2002;30:1899-901. 9) 藤井洋泉,小坂順子,川西 進,他. ノルエピネフリン抵 抗性敗血症性ショックに対するバソプレシンの有効性. 日 集中医誌. 2008;15: 7-71. 10) Tsuneyoshi I, Boyle WA. Vasopressin: new uses for an old drug. Contemporary Crit Care. 2003;1:1-12. 11) Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487-93. 12) Fushimi K, Uchida S, Hara Y, et al. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature. 1993;3 1:549-52. 13) Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides. 2005;2 : 2500-4. 14) Jochberger S, Morgenthaler NG, Mayr VD, et al. Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab. 200 ;91:4381. 15) Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 200 ;52:112-9.","PeriodicalId":282021,"journal":{"name":"Nihon Shuchu Chiryo Igakukai Zasshi","volume":"205 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Shuchu Chiryo Igakukai Zasshi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3918/JSICM.15.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
1) Kurtzman NA, Boonjarern S. Physiology of antidiuretic hormone and the interrelationship between the hormone and the kidney. Nephron. 1975;15:1 7-85. 2) Kamegai M, Kristensen MS, Warberg J, et al. Carotid baroreflexes and plasma vasopressin in humans during head-up tilt. Am J Physiol. 1992;2 3:R318-23. 3) Tsuneyoshi I, Onomoto M, Yonetani A, et al. Low-dose vasopressin infusion in patients with severe vasodilatory hypotension after prolonged hemorrhage during general anesthesia. J Anesth. 2005;19:170-3. 4) Stoiser B, Mörtl D, Hülsmann M, et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest. 200 ;3 :771-8. 5) Hjelmqvist H, Ullman J, Gunnarsson U, et al. Haemodynamic and humoral responses to repeated hypotensive haemorrhage in conscious sheep. Acta Physiol Scand. 1991;143:554. ) Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med. 2003; 31:1752-8. 7) Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-5. 8) Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med. 2002;30:1899-901. 9) 藤井洋泉,小坂順子,川西 進,他. ノルエピネフリン抵 抗性敗血症性ショックに対するバソプレシンの有効性. 日 集中医誌. 2008;15: 7-71. 10) Tsuneyoshi I, Boyle WA. Vasopressin: new uses for an old drug. Contemporary Crit Care. 2003;1:1-12. 11) Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487-93. 12) Fushimi K, Uchida S, Hara Y, et al. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature. 1993;3 1:549-52. 13) Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides. 2005;2 : 2500-4. 14) Jochberger S, Morgenthaler NG, Mayr VD, et al. Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab. 200 ;91:4381. 15) Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 200 ;52:112-9.